Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 5.6M | 7.0M | 8.1M | 7.7M | -- |
| Operating Revenue | 5.6M | 7.0M | 8.1M | 7.7M | -- |
| Cost Of Revenue | 1.3M | 1.8M | 1.7M | 1.5M | -- |
| Gross Profit | 4.2M | 5.2M | 6.5M | 6.1M | -- |
| Selling General And Administration | 2.7M | 3.1M | 2.8M | 2.8M | -- |
| General And Administrative Expense | 2.7M | 3.1M | 2.8M | 2.8M | -- |
| Other Operating Expenses | 2.9M | 3.3M | 3.3M | 3.1M | -- |
| Operating Expense | 5.7M | 6.3M | 6.0M | 5.9M | -- |
| Operating Income | -1.4M | -1.1M | 444,000 | 217,000 | -- |
| EBIT | -4.1M | -12.7M | 706,000 | -360,000 | -- |
| Interest Expense | 117,000 | 17,000 | 3,000 | 14,000 | -- |
| Interest Expense Non Operating | 117,000 | 17,000 | 3,000 | 14,000 | -- |
| Interest Income | -- | -- | 4,000 | 7,000 | 1,000 |
| Interest Income Non Operating | -- | -- | 4,000 | 7,000 | 1,000 |
| Net Interest Income | -117,000 | -17,000 | 1,000 | -7,000 | -- |
| Other Income Expense | -2.6M | -11.6M | 258,000 | -584,000 | -- |
| Other Non Operating Income Expenses | -- | 29,000 | 195,000 | -- | 114,000 |
| Special Income Charges | -2.6M | -11.6M | 0.00 | -568,000 | -- |
| Gain On Sale Of Security | -32,000 | -48,000 | 63,000 | -16,000 | -- |
| Pretax Income | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 25,200 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Net Income From Continuing Operation Net Minority Interest | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Net Income Including Noncontrolling Interests | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Net Income Common Stockholders | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Net Income | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| EBITDA | -3.2M | -11.5M | 1.8M | 707,000 | -- |
| Normalized EBITDA | -548,000 | 136,000 | 1.7M | 1.3M | -- |
| Reconciled Depreciation | 881,000 | 1.2M | 1.1M | 1.1M | -- |
| Basic EPS | -0.01 | -0.03 | 0.00 | -0.00 | -- |
| Diluted EPS | -0.01 | -0.03 | 0.00 | -0.00 | -- |
| Basic Average Shares | 485.3M | 485.3M | 485.3M | 436.4M | -- |
| Diluted Average Shares | 485.3M | 485.3M | 486.2M | 436.4M | -- |
| Total Unusual Items | -2.6M | -11.6M | 63,000 | -584,000 | -- |
| Total Unusual Items Excluding Goodwill | -2.6M | -11.6M | 63,000 | -584,000 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.40 | 0.00 | -- |
| Normalized Income | -1.5M | -1.1M | 665,200 | 210,000 | -- |
| Diluted NI Availto Com Stockholders | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Gain On Sale Of Ppe | -73,000 | 29,000 | -- | -- | -- |
| Impairment Of Capital Assets | 2.5M | 11.6M | 0.00 | 568,000 | -- |
| Net Income Continuous Operations | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Net Non Operating Interest Income Expense | -117,000 | -17,000 | 1,000 | -7,000 | -- |
| Other Gand A | 2.7M | 3.0M | 2.7M | 2.7M | -- |
| Other Special Charges | -- | -- | -- | -- | -3.5M |
| Reconciled Cost Of Revenue | 1.3M | 1.8M | 1.7M | 1.5M | -- |
| Salaries And Wages | 14,000 | 29,000 | 81,000 | 135,000 | -- |
| Total Expenses | 7.0M | 8.1M | 7.7M | 7.4M | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 708,000 | 692,000 | 795,000 | 5.4M | -- |
| Cash Cash Equivalents And Short Term Investments | 708,000 | 692,000 | 795,000 | 5.4M | -- |
| Cash Equivalents | -- | -- | 0.00 | 4.0M | 0.00 |
| Cash Financial | -- | -- | 795,000 | 1.4M | 4.5M |
| Receivables | 1.7M | 1.8M | 1.1M | 2.6M | -- |
| Prepaid Assets | 980,000 | 903,000 | 903,000 | 658,000 | -- |
| Current Assets | 3.4M | 3.4M | 2.8M | 8.7M | -- |
| Gross PPE | 63.8M | 65.7M | 69.9M | 63.2M | -- |
| Accumulated Depreciation | -36.6M | -34.7M | -23.0M | -23.3M | -- |
| Net PPE | 27.3M | 31.0M | 46.9M | 39.9M | -- |
| Total Non Current Assets | 27.3M | 31.0M | 46.9M | 39.9M | -- |
| Total Assets | 30.6M | 34.4M | 49.7M | 48.6M | -- |
| Current Debt And Capital Lease Obligation | -- | -- | 32,000 | 37,000 | 31,000 |
| Accounts Payable | 1.8M | 3.2M | 2.4M | 2.4M | -- |
| Payables | 1.8M | 3.2M | 2.4M | 2.4M | -- |
| Payables And Accrued Expenses | 1.8M | 3.2M | 3.0M | 3.2M | -- |
| Current Accrued Expenses | -- | 599,000 | 646,000 | 841,000 | 505,000 |
| Current Liabilities | 1.8M | 3.2M | 3.1M | 3.2M | -- |
| Long Term Debt | 1.7M | -- | -- | -- | -- |
| Long Term Debt And Capital Lease Obligation | 1.7M | -- | 0.00 | 31,000 | 68,000 |
| Long Term Capital Lease Obligation | -- | -- | 0.00 | 31,000 | 68,000 |
| Total Non Current Liabilities Net Minority Interest | 4.8M | 3.5M | 5.1M | 3.4M | -- |
| Total Liabilities Net Minority Interest | 6.6M | 6.7M | 8.2M | 6.7M | -- |
| Common Stock | 118.8M | 118.8M | 118.8M | 118.8M | -- |
| Capital Stock | 118.8M | 118.8M | 118.8M | 118.8M | -- |
| Additional Paid In Capital | 8.2M | 8.1M | 8.1M | 8.0M | -- |
| Retained Earnings | -100.0M | -95.8M | -83.1M | -83.8M | -- |
| Gains Losses Not Affecting Retained Earnings | -2.9M | -3.4M | -2.3M | -1.1M | -- |
| Other Equity Adjustments | -- | -- | -2.3M | -1.1M | -- |
| Common Stock Equity | 24.0M | 27.7M | 41.5M | 41.9M | -- |
| Stockholders Equity | 24.0M | 27.7M | 41.5M | 41.9M | -- |
| Total Equity Gross Minority Interest | 24.0M | 27.7M | 41.5M | 41.9M | -- |
| Total Capitalization | 25.7M | 27.7M | 41.5M | 41.9M | -- |
| Net Tangible Assets | 24.0M | 27.7M | 41.5M | 41.9M | -- |
| Tangible Book Value | 24.0M | 27.7M | 41.5M | 41.9M | -- |
| Working Capital | 1.6M | 199,000 | -284,000 | 5.5M | -- |
| Invested Capital | 25.7M | 27.7M | 41.5M | 41.9M | -- |
| Total Debt | 1.7M | 0.00 | 32,000 | 68,000 | -- |
| Net Debt | 992,000 | -- | -- | -- | -- |
| Share Issued | 485.3M | 485.3M | 485.3M | 485.3M | -- |
| Ordinary Shares Number | 485.3M | 485.3M | 485.3M | 485.3M | -- |
| Buildings And Improvements | -- | -- | -- | -- | 143,000 |
| Capital Lease Obligations | -- | 0.00 | 32,000 | 68,000 | 99,000 |
| Current Capital Lease Obligation | -- | 0.00 | 32,000 | 37,000 | 31,000 |
| Duefrom Related Parties Current | 1.7M | 1.8M | 1.1M | 2.6M | -- |
| Long Term Provisions | 3.1M | 3.5M | 5.1M | 3.4M | -- |
| Other Properties | 490,000 | 490,000 | 490,000 | 489,000 | -- |
| Other Receivables | 6,000 | 7,000 | 9,000 | 11,000 | -- |
| Properties | 63.3M | 65.2M | 69.4M | 62.7M | -- |
| Restricted Cash | -- | -- | -- | 0.00 | 40,000 |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -392,000 | -273,000 | 2.1M | 835,000 | -- |
| Cash Flow From Continuing Operating Activities | -392,000 | -273,000 | 2.1M | 835,000 | -- |
| Depreciation And Amortization | 2,000 | 25,000 | -- | -- | -- |
| Depreciation Amortization Depletion | 881,000 | 1.2M | 1.1M | 1.1M | -- |
| Stock Based Compensation | 14,000 | 29,000 | 81,000 | 135,000 | -- |
| Change In Working Capital | 178,000 | -574,000 | 123,000 | -597,000 | -- |
| Other Non Cash Items | 152,000 | 178,000 | 167,000 | 43,000 | -- |
| Capital Expenditure | -56,000 | -397,000 | -5.5M | -3.1M | -- |
| Purchase Of PPE | -- | -- | -5.5M | -3.1M | -1.2M |
| Net PPE Purchase And Sale | 193,000 | 0.00 | -5.5M | -3.1M | -- |
| Investing Cash Flow | 265,000 | 228,000 | -6.7M | -4.1M | -- |
| Cash Flow From Continuing Investing Activities | 265,000 | 228,000 | -6.7M | -4.1M | -- |
| Issuance Of Debt | 1.7M | 0.00 | -- | -- | -- |
| Repayment Of Debt | 0.00 | -32,000 | -40,000 | -36,000 | -- |
| Net Issuance Payments Of Debt | 1.7M | -32,000 | -40,000 | -36,000 | -- |
| Issuance Of Capital Stock | -- | -- | 0.00 | 4.2M | 16.5M |
| Net Common Stock Issuance | -- | -- | 0.00 | 4.2M | 16.5M |
| Financing Cash Flow | 139,000 | -32,000 | -40,000 | 4.1M | -- |
| Cash Flow From Continuing Financing Activities | 139,000 | -32,000 | -40,000 | 4.1M | -- |
| Effect Of Exchange Rate Changes | 4,000 | -26,000 | 21,000 | -16,000 | -- |
| Changes In Cash | 12,000 | -77,000 | -4.6M | 898,000 | -- |
| Beginning Cash Position | 692,000 | 795,000 | 5.4M | 4.5M | -- |
| End Cash Position | 708,000 | 692,000 | 795,000 | 5.4M | -- |
| Free Cash Flow | -448,000 | -670,000 | -3.4M | -2.3M | -- |
| Interest Paid Supplemental Data | 117,000 | 16,000 | 12,000 | 9,000 | -- |
| Asset Impairment Charge | 2.5M | 11.6M | 0.00 | 568,000 | -- |
| Capital Expenditure Reported | -56,000 | -397,000 | -5.5M | -- | -- |
| Common Stock Issuance | -- | -- | 0.00 | 4.2M | 16.5M |
| Depletion | 879,000 | 1.2M | -- | -- | -- |
| Depreciation | 2,000 | 25,000 | -- | -- | -- |
| Gain Loss On Sale Of PPE | 73,000 | 0.00 | -- | -- | -- |
| Long Term Debt Issuance | 1.7M | 0.00 | -- | -- | -- |
| Long Term Debt Payments | 0.00 | -32,000 | -40,000 | -36,000 | -- |
| Net Foreign Currency Exchange Gain Loss | -39,000 | -6,000 | -35,000 | -7,000 | -- |
| Net Income From Continuing Operations | -4.2M | -12.7M | 703,000 | -374,000 | -- |
| Net Intangibles Purchase And Sale | 133,000 | 649,000 | 0.00 | -- | -- |
| Net Long Term Debt Issuance | 1.7M | -32,000 | -40,000 | -36,000 | -- |
| Net Other Financing Charges | -1.6M | -- | -- | -- | -6,000 |
| Net Other Investing Changes | -5,000 | -24,000 | -1.2M | -970,000 | -- |
| Net Short Term Debt Issuance | -- | -- | 0.00 | 0.00 | -12.6M |
| Operating Gains Losses | 34,000 | -6,000 | -35,000 | -7,000 | -- |
| Sale Of Intangibles | 133,000 | 649,000 | 0.00 | -- | -- |
| Sale Of PPE | 193,000 | 0.00 | -- | -- | -- |
| Short Term Debt Payments | -- | -- | 0.00 | 0.00 | -12.6M |
| Unrealized Gain Loss On Investment Securities | -- | -- | -- | 0.00 | 1.5M |